13G Filing: Sabby Capital and Vistagen Therapeutics Inc. (VTGN)

Page 5 of 7 – SEC Filing

( (c)
Number of shares as to which the person has:

Sabby Volatility Warrant Master Fund, Ltd.

( (i)
Sole power to vote or to direct the vote
0
,( (ii)
Shared power to vote or to direct the vote
2,000,000
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
2,000,000
.Sabby Management, LLC

(i)
Sole power to vote or to direct the vote
0
,( (ii)
Shared power to vote or to direct the vote
2,000,000
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
2,000,000
.Hal Mintz

( (i)
Sole power to vote or to direct the vote
0
,( (ii)
Shared power to vote or to direct the vote
2,000,000
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
2,000,000
.As calculated in accordance with Rule 13d-3 of the Securities Exchange
Act of 1934, as amended, (i) Sabby Volatility Warrant Master Fund,
Ltd. beneficially owns 2,000,000 shares of the Issuer’s common stock
(Common Stock), representing approximately 9.15% of the Common Stock,
and (ii) Sabby Management, LLC and Hal Mintz each beneficially own
2,000,000 shares of the Common Stock, representing approximately 9.15% of
the Common Stock. Sabby Management, LLC and Hal Mintz do not directly own
any shares of Common Stock, but each indirectly owns 2,000,000 shares of
Common Stock. Sabby Management, LLC, a Delaware limited liability company,
indirectly owns 2,000,000 shares of Common Stock because it serves as the
investment manager of Sabby Volatility Warrant Master Fund, Ltd. Mr.
Mintz indirectly owns 2,000,000 shares of Common Stock in his capacity
as manager of Sabby Management, LLC.

Item 5.
Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the
following [_].

Follow Vistagen Therapeutics Inc. (OTCMKTS:VTGN)